A series of pilot schemes set up by the UK in partnership with the pharma industry will test ways to get new medicines to ...

Roche's chief medical officer, Levi Garraway. Roche has thrown down the gauntlet to Amgen and Bristol Myers Squibb with new ...

For the first time, children in the US as young as two with the blood disorders sickle cell disease and beta thalassaemia are ...

AstraZeneca has returned to China's CSPC Pharma to fill its R&D pipeline, reaching a new agreement to develop drugs for ...

As the US relaxes an export ban on Anthropic's advanced AI tools, the company formally launched Claude Science, an AI ...

The agency, consultancy, and investor segments saw a wave of senior-level appointments across April and May, as organisations ...

As of 2026, women remain underrepresented in STEM fields, but initiatives like the Women and Underrepresented Minorities in ...

Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to ...

Sanofi is preparing to expand the use of its Pompe therapy Nexviazyme, currently approved only for late-onset cases of the ...

HHS acknowledged in a statement on Operation Trailblazer that "a growing share of early-stage clinical research has moved ...

Eli Lilly's LillyDirect sales channel, which has become an important driver of sales of its weight-loss therapies in the US, ...